Redefining the operational backbone of biopharma.
TransferAI is bringing speed, rigor, and scalability to biopharma operations.
Breakthrough science deserves best-in-class operations.
We're building TransferAI to redefine how biopharma teams move science forward enabling them to research, analyze, draft, and deliver together with precision that compounds over time. It's a platform for the kind of collaboration this industry has never had — operational expertise, multiplied by accelerated intelligence.
It's purpose-built for biopharma and designed around one conviction, when the science is ready, operational complexity should never be the reason patients wait.
“Over two decades in this industry, I know exactly where the time goes and where it shouldn't. I watched exceptional people spend their days on labor-intensive workflows instead of higher value work. I wish I had Sofie then. But we have it now, so do you.”
Ryan Hawkins
Co-Founder, TransferAI
Founding Team
Built by operators.
Designed for the industry.
Ryan's 25+ years span both CDMOs and biotechs where he built and led teams across biopharma's most complex operations. He scaled a CDMO from brownfield to a $250M P&L, led complex tech transfers, and helped grow the business through a major acquisition. When he describes what's broken, he's speaking from both sides of the table.
Joaquin has taken vertical SaaS companies from startup to $100M ARR, leading commercialization and go-to-market across multiple high-growth markets. He's a product person as much as a commercial leader because in regulated industries trust is earned through the product not around it. That conviction is why TransferAI is built the way it is.
Mark is a serial entrepreneur and agentic AI architect who has built multiple software companies from the ground up. He thinks in systems, specifically how to make enterprise-grade AI feel like something anyone would actually want to use. At TransferAI, that philosophy is what sits between complex biopharma workflows and the people who need to execute them every day.
